Mutual funds bought 505 smallcap stocks in March crash. Two weeks later, they're winning bigIndian mutual funds bought smallcap stocks in March when retail investors sold. This strategy paid off as the Nifty Smallcap 250 index rose...
17 Apr, 2026, 08.55 AM IST
Dr. Lal PathLabs shares turn ex-bonus tomorrow for 1:1 issue, last day to buy for eligibilityAs per the corporate filings, the company will issue one fully paid-up bonus equity share of face value Rs 10 for every one existing fully ...
18 Dec, 2025, 07.46 AM IST
Dr Lal Path Labs announces 1:1 bonus issue, declares Rs 7/share interim dividendDiagnostics services company Dr Lal Path Labs on Friday announced an interim dividend of Rs 7 per equity share for the financial year 2025-...
31 Oct, 2025, 03.56 PM IST
Dr Lal Path Labs Q2 Results: Co posts bigger-than-expected profit at Rs 129 crore on demand for medical testsDr. Lal PathLabs, India's top diagnostics firm by revenue, reported a bigger-than-expected second-quarter profit on Wednesday, driven by co...
23 Oct, 2024, 05.04 PM IST
Dr Lal PathLabs Q1 FY24 net profit rises 44% to Rs 84 croreDr Lal PathLabs' Q1FY24 net profit surged 44% YoY to INR84 crore due to the rise in non-Covid testing and higher realisations, while non-Co...
27 Jul, 2023, 07.18 PM IST
Dr Lal Path Labs cracks 9% on weak Q2 showThe company’s revenue from operations, however, grew 7.1% to Rs 533.8 crore during the period under review, from Rs 498.4 crore in the corr...
09 Nov, 2022, 02.07 PM IST
Dr Lal Path Labs Q2 PAT declines 25 pc to Rs 72.4 crThe company had posted a profit after tax (PAT) of Rs 96.3 crore in the year-ago period, it said in a BSE filing.Its revenue from operation...
08 Nov, 2022, 07.07 PM IST
Dr Lal PathLabs to use drones for transporting blood samplesThe use of drones would expand Dr Lal PathLabs services of high-quality and advanced diagnostics to underserved and inaccessible locations,...
05 Apr, 2022, 04.41 PM IST
Day Trade Guide: 2 stock recommendations for FridayA sustained trade beyond 17,400 will extend the uptrend taking Nifty50 higher to the levels of 17,500-17,600. However, failing to trade and...
02 Dec, 2021, 06.54 PM IST
Dr Lal PathLabs Q2 results: Net profit up 11% at Rs 96 croreOperating revenue of the company increased by 15.4 per cent in Q2 FY22 to Rs 498.4 crore as compared with Rs 431.9 crore in Q2 FY21, Dr Lal...
27 Oct, 2021, 12.13 AM IST
Dr Lal Path Labs buys Suburban Diagnostics in all-cash dealThe development comes amid consolidation and heightened investor interest in the diagnostics sector due to the Covid-19 pandemic.
26 Oct, 2021, 11.04 PM IST
Valuation of diagnostic stocks unsustainable: Sandip Sabharwal"I think the valuation across the board is excessive, be it Metropolis or Dr Lal Path Labs. Thyrocare is slightly less expensive, but it is...
21 Jun, 2021, 03.20 PM IST
Dr Lal PathLabs Q1 results: Net profit declines 52% to Rs 28.4 croreThe company had posted a net profit of Rs 59.1 crore for the corresponding period of the previous fiscal, Dr Lal PathLabs said in a filing ...
31 Jul, 2020, 04.24 PM IST
CLSA maintains 'buy' on Dr Lal PathLabsDr Lal PathLabs' volume growth in the past two quarters has been encouraging.
09 Feb, 2018, 03.24 PM IST
Nomura upgrades Dr Lal PathLabs to 'buy' from 'neutral'The brokerage said growth in recent times in Dr Lal PathLabs has been hit by demonetisation but it remains constructive on long term growth...
21 Mar, 2017, 02.14 PM IST
- Dr Lal Path Labs eying revenues of Rs 350 cr in FY12
Dr Lal Path Labs, which operates Asia's largest diagnostics centre in the capital, runs 70 laboratories across the country.
15 May, 2011, 11.49 AM IST
- TA Associates buys minority stake in Lal PathLabs
TA Associates made a minority investment in Dr Lal PathLabs by purchasing half of Sequoia Capital’s stake in the company for an undisclosed...
27 Aug, 2010, 01.44 AM IST